பலா சுஜிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பலா சுஜிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பலா சுஜிக் Today - Breaking & Trending Today

Researchers use new way to detect high-risk Human Papilloma Virus


Researchers use new way to detect high-risk Human Papilloma Virus
A study led by Queen Mary University of London researchers has compared the performance and acceptability of a urine test and four different vaginal self-sampling collection devices to detect high risk Human Papilloma Virus (HPV).
Uptake of cervical screening has been declining in the UK in recent years, and self-sampling is an attractive alternative to clinician collected samples, initially in non-attenders but potentially for all women as the primary option.
Jack Cuzick, Study Corresponding Author and Professor, Queen Mary University of London
Related Stories
Cost and simplicity of use are important factors, and in low- and middle-income countries self-sampling may prove to be the only practical cost-effective option. High performance and acceptability of self-sampling is essential if this is to become the first option. Understanding preferences for a urine rather than a vaginal sample is imp ....

United Kingdom , City Of , Jack Cuzick , Becton Dickinson Onclarity , Emily Henderson , Queen Mary University Of London , Queen Mary Wolfson Institute Of Preventive Medicine , Queen Mary University , Human Papillomavirus , Study Corresponding Author , Royal London Hospital , Queen Mary , Wolfson Institute , Preventive Medicine , Urine Test , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , பலா சுஜிக் , எமிலி ஹென்டர்சன் , ராணி மேரி பல்கலைக்கழகம் ஆஃப் லண்டன் , ராணி மேரி ஓநாய் நிறுவனம் ஆஃப் ப்ரெவெஂடிவ் மருந்து , ராணி மேரி பல்கலைக்கழகம் , அரச லண்டன் மருத்துவமனை , ராணி மேரி , ஓநாய் நிறுவனம் , ப்ரெவெஂடிவ் மருந்து ,

Evaluating HPV self-sampling


 E-Mail
A study led by Queen Mary University of London researchers has compared the performance and acceptability of a urine test and four different vaginal self-sampling collection devices to detect high risk Human Papilloma Virus (HPV).
Corresponding author Professor Jack Cuzick from Queen Mary University of London said: Uptake of cervical screening has been declining in the UK in recent years, and self-sampling is an attractive alternative to clinician collected samples, initially in non-attenders but potentially for all women as the primary option.
Cost and simplicity of use are important factors, and in low- and middle-income countries self-sampling may prove to be the only practical cost-effective option. High performance and acceptability of self-sampling is essential if this is to become the first option. Understanding preferences for a urine rather than a vaginal sample is important, and perhaps a choice should be offered. ....

United Kingdom , City Of , Deepali Patel , Caroline Reuter , Michelle Kleeman , Attila Lorincz , Anna Parberry , Tony Hollingworth , Belinda Nedjai , Janet Austin , Louise Cadman , Mark Jitlal , Becton Dickinson Onclarity , Lesley Ashdown Barr , Jack Cuzick , Queen Mary University Of London , Queen Mary Wolfson Institute Of Preventive Medicine , Queen Mary University , Human Papillomavirus , Professor Jack Cuzick , Royal London Hospital , Queen Mary , Wolfson Institute , Preventive Medicine , Cancer Epidemiology , Medicine Health ,

More accurate method to predict long term outcomes for pre-invasive breast cancer


 E-Mail
A study by Queen Mary University of London researchers, funded by Cancer Research UK, confirms the role of the oestrogen receptor biomarker in ductal carcinoma in situ and presents a new and more accurate method to predict long term outcomes for this pre-invasive stage of breast cancer. The study is published in
Clinical Cancer Research.
Oestrogen receptor (ER), a protein expressed in some breast cancer cells, is routinely tested in invasive breast cancer to predict long-term outcomes select treatment options. Its role in ductal carcinoma in situ (DCIS) has been previously unclear, and it is not generally evaluated in this pre-invasive stage of breast cancer. The new research confirms the role of ER in predicting long-term outcomes in DCIS, and the authors report a new and more accurate method to evaluate ER for predicting long-term outcomes in DCIS. ....

United Kingdom , Ians Fentiman , Mangesha Thorat , Louisej Jones , Paulinem Levey , Sarahe Pinder , Mangesh Thorat , Jack Cuzick , Michelle Mitchell , Nigelj Bundred , Queen Mary University Of London , Cancer Research United Kingdom , Clinical Cancer Research , Queen Mary University , Clinical Cancer , Cancer Res , Medicine Health , Breast Cancer , ஒன்றுபட்டது கிஂக்டம் , மங்கேஷ் தோராத் , பலா சுஜிக் , மைக்கேல் மிட்செல் , ராணி மேரி பல்கலைக்கழகம் ஆஃப் லண்டன் , புற்றுநோய் ஆராய்ச்சி ஒன்றுபட்டது கிஂக்டம் , மருத்துவ புற்றுநோய் ஆராய்ச்சி , ராணி மேரி பல்கலைக்கழகம் ,